CD4 and pancreatic neoplasm: While we did not find a relationship between peripheral CD4+ Tregs and the prognosis of patients with MPC, previous studies have reported high levels of circulating CD4+ Tregs, leading to poor prognosis in patients with pancreatic cancer [13, 15].